(Q36615665)

15 August 2017

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions (English)

1 reference

15 August 2017

1 reference

4

1 reference

15 August 2017

25

1 reference

15 August 2017

Olli-Pekka Kallioniemi

27

1 reference

15 August 2017

29

1 reference

15 August 2017

P Radice

15

0 references

Håkan Olsson

object named as

H Olsson

11

0 references

Jan Lubiński

22

object named as

J Lubinski

1 reference

15 August 2017

31

D F Easton

1 reference

15 August 2017

9

J L Hopper

1 reference

15 August 2017

16

S Manoukian

1 reference

15 August 2017

20

H Anton-Culver

1 reference

15 August 2017

3

J Peto

1 reference

15 August 2017

30

P D P Pharoah

1 reference

15 August 2017

10

M C Southey

1 reference

15 August 2017

6

S A Narod

1 reference

15 August 2017

1

A C Antoniou

1 reference

15 August 2017

17

D M Eccles

1 reference

15 August 2017

2

A P Cunningham

1 reference

15 August 2017

23

J Gronwald

1 reference

15 August 2017

24

B Gorski

1 reference

15 August 2017

F Lalloo

5

1 reference

15 August 2017

H A Risch

7

1 reference

15 August 2017

J E Eyfjord

8

1 reference

15 August 2017

O Johannsson

12

1 reference

15 August 2017

A Borg

13

1 reference

15 August 2017

B Pasini

14

1 reference

15 August 2017

N Tang

18

1 reference

15 August 2017

E Olah

19

1 reference

15 August 2017

E Warner

21

1 reference

15 August 2017

K Syrjakoski

26

1 reference

15 August 2017

H Eerola

28

1 reference

15 August 2017

language of work or name

English

0 references

publication date

18 March 2008

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

98

1 reference

15 August 2017

8

1 reference

15 August 2017

1457-1466

1 reference

Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361716

Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361716

Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361716

Variation of breast cancer risk among BRCA1/2 carriers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361716

Breast cancer risk among male BRCA1 and BRCA2 mutation carriers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361716

Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361716

A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361716

Genome-wide association study identifies novel breast cancer susceptibility loci

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361716

PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361716

ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361716

A genome wide linkage search for breast cancer susceptibility genes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361716

Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361716

BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361716

Cancer risks and mortality in heterozygous ATM mutation carriers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361716

The BOADICEA model of genetic susceptibility to breast and ovarian cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361716

CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361716

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361716

Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361716

Cancer Incidence in BRCA1 mutation carriers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361716

The effect of a single BRCA2 mutation on cancer in Iceland

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361716

BRCA1 and BRCA2 mutations in a population-based study of male breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361716

A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361716

Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361716

The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361716

How many more breast cancer predisposition genes are there?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361716

Variation in cancer risks, by mutation position, in BRCA2 mutation carriers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361716

Cancer risks in BRCA2 mutation carriers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361716

Determining Carrier Probabilities for Breast Cancer–Susceptibility Genes BRCA1 and BRCA2

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361716

Study of a single BRCA2 mutation with high carrier frequency in a small population

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361716

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361716

Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361716

Assessing BRCA carrier probabilities in extended families.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361716

Cancer risks in BRCA2 families: estimates for sites other than breast and ovary.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361716

BRCA mutations and risk of prostate cancer in Ashkenazi Jews

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361716

A breast cancer prediction model incorporating familial and personal risk factors

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361716

On the use of familial aggregation in population-based case probands for calculating penetrance

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361716

Prostate Cancer Progression and Survival in BRCA2 Mutation Carriers

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361716

A common coding variant in CASP8 is associated with breast cancer risk

4 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361716

Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles

4 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361716

Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group

4 December 2018

1 reference

12 December 2020

Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study

1 reference

12 December 2020

Cancer Risk Estimates for BRCA1 Mutation Carriers Identified in a Risk Evaluation Program

1 reference

12 December 2020

Familial Risks, Early-Onset Breast Cancer, and BRCA1 and BRCA2 Germline Mutations

1 reference

12 December 2020

Prediction of pathogenic mutations in patients with early-onset breast cancer by family history

1 reference

12 December 2020

Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer

1 reference

12 December 2020

A new look at the statistical model identification

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6604305

7 January 2021

inferred from DOI database lookup

20q11.1 amplification in giant-cell tumor of bone: Array CGH, FISH, and association with outcome.

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6604305

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/SJ.BJC.6604305

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

18349832

1 reference